McCann FitzGerald LLP advising Alkermes plc on its acquisition of Avadel Pharmaceuticals plc

We are delighted to be advising Alkermes plc on its acquisition of Avadel Pharmaceuticals plc, a commercial-stage biopharmaceutical company in a deal valued at up to $2.1 billion.